Actively Recruiting
The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis
Led by Showa Inan General Hospital · Updated on 2025-05-15
100
Participants Needed
1
Research Sites
347 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The traditional Japanese medicine, Keishi-ka-shakuyaku-daio-to is administered to patients with symptomatic pneumatosis cystoides intestinalis (PCI) as compared with lactomin for 8 weeks.
CONDITIONS
Official Title
The Beneficial Effect of TJ-134 for Patients With Symptomatic Pneumatosis Cystoides Intestinalis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Typical findings of pneumatosis cystoides intestinalis (PCI) on colonoscopy; line or pebble-like sessile cysts distributed around the colon with normal overlying mucosa
You will not qualify if you...
- Patients who cannot take Keishi-ka-shakuyaku-daio-to (TJ-134)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Showa Inan General hospital
Komagane, Nagano, Japan, 399-4117
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here